Skip to main content

Preoperative findings, pathological stage PSA recurrence in men with prostate cancer incidentally detected at radical cystectomy: our experience in 242 cases

Abstract

Purpose

Preoperative findings, pathological stage PSA recurrence in patients with prostate cancer incidentally detected (iPCa) at radical cystectomy (RCP) were prospectively evaluated.

Methods

From July 2000 to July 2013, 242 men 71 years old (median) underwent RCP; preoperatively, all patients underwent digital rectal examination (DRE), total and free/total PSA. The bladder was totally examined; moreover, the prostate gland was step-sectioned at 4-mm intervals. The incidence of iPCa that fulfilled criteria for clinically significant iPCa was recorded: tumor volume ≥0.5 mL, Gleason grade ≥4, extracapsular extension, seminal vesicle invasion, lymph node metastasis or positive surgical margins. In the presence of iPCa, the patients underwent PSA evaluation during the follow-up and recurrence was defined as two subsequent rises >0.2 ng/mL.

Results

Among the 50 (20.6 %) out of 242 patients submitted to RCP, an iPCa was found and 18 (36 %) of them met criteria for insignificant iPCa; moreover, 30 % of the patients had apex involvement. Median total PSA and PSA F/T values were not significantly different in the presence versus the absence of iPCa (2.6 vs 2.7 ng/mL and 26 vs 27 %; p > 0.05) and between significant versus insignificant iPCa (p > 0.05). None of the patients during the follow-up (median 58 months; range 6–102 months) had PSA recurrence.

Conclusions

PSA and PSA F/T values are provided for poor accuracy in distinguishing preoperatively significant from insignificant iPCa; however, the life expectancy of the patients is dramatically influenced by bladder cancer pTN (in our series, none developed PSA failure). In younger men in whom a prostate-sparing cystectomy could be proposed, an accurate preoperative evaluation should be mandatory to rule out significant iPCa at the risk of apex involvement (in our series equal to 30 % of the cases).

This is a preview of subscription content, access via your institution.

References

  1. Cindolo L, Benincasa G, Autorino R et al (2001) Prevalence of silent prostatic adenocarcinoma in 165 patients undergone cystoprostatectomy: a retrospective study. Oncol Rep 8:269–271

    CAS  PubMed  Google Scholar 

  2. Winkler MH, Livni N, Mannion EM, Hrouda D, Christmas T (2007) Characteristics of incidental prostatic adenocarcinoma in contemporary radical cystoprostatectomy specimens. BJU Intl 99:554–558. doi:10.1111/j.1464-410X.2006.06660.x

    Article  Google Scholar 

  3. Zhu YP, Ye DW, Yao XD et al (2008) Prevalence of incidental prostate cancer in patients undergoing radical cystoprostatectomy: data from China and other Asian countries. Asian J Androl 11:104–108. doi:10.1038/aja.2008.15

    PubMed Central  PubMed  Article  Google Scholar 

  4. Kouriefs C, Fazili T, Masood S, Naseem MS, Mufti GR (2005) Incidentally detected prostate cancer in cystoprostatectomy specimens. Urol Int 75:213–216. doi:10.1159/000087796

    CAS  PubMed  Article  Google Scholar 

  5. Abdelhady M, Abusamra A, Pautler SE, Chin JL, Izawa JI (2007) Clinically significant prostate cancer found incidentally in radical cystoprostatectomy specimens. BJU Int 99:326–329. doi:10.1111/j.1464-410X.2006.06558.x

    PubMed  Article  Google Scholar 

  6. Ward JF, Bartsch G, Sebo TJ, Pinggera GM, Blute ML, Zincke H (2004) Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0–2 ng/mL) incidental to cystoprostatectomy: is PSA a useful indicator of clinical significance? Urol Oncol 22:40–47. doi:10.1016/S1078-1439(03)00093-0

    CAS  PubMed  Article  Google Scholar 

  7. Nevoux P, Ouzzane A, Ahmed HU, Emberton M, Montironi R, Presti JC, Villers A (2012) Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series. BJU Int 110:517–523. doi:10.1111/j.1464-410X.2011.10776.x

    PubMed  Article  Google Scholar 

  8. Hosseini SY, Danesh AK, Parvin M, Basiri A, Javadzadeh T, Safarinejad MR, Nahabedian A (2007) Incidental prostatic adenocarcinoma in patients with PSA less than 4 ng/mL undergoing radical cystoprostatectomy for bladder cancer in Iranian men. Int Braz J Urol 33:167–173

    CAS  PubMed  Article  Google Scholar 

  9. Sivalingam S, Drachenberg D (2013) The incidence of prostate cancer and urothelial cancer in the prostate in cystoprostatectomy specimens in a tertiary care Canadian centre. Can Urol Assoc J 7:35–38. doi:10.5489/cuaj.212

    PubMed Central  PubMed  Article  Google Scholar 

  10. Mazzucchelli R, Barbisan F, Scarpelli M, Lopez-Beltran A, van der Kwast TH, Cheng L, Montironi R (2009) Is incidentally detected prostate cancer in patients undergoing radical cystoprostatectomy clinically significant? Am J Clin Pathol 131:279–283. doi:10.1309/AJCP4OCYZBAN9TJU

    PubMed  Article  Google Scholar 

  11. Haas GP, Delongchamps N, Brawley OW, Wang CY, de la Roza G (2008) The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol 15:3866–3871

    PubMed Central  PubMed  Google Scholar 

  12. Bostwick DG, Grignon DJ, Hammond ME et al (2000) Prognostic factors in prostate cancer. College of American pathologists consensus statement 1999. Arch Pathol Lab Med 124:995–1000. doi:10.1043/0003-9985(2000)

    CAS  PubMed  Google Scholar 

  13. Epstein JI, Walsh PC, Carmichael M, Brendler CB (1994) Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 271:368–374

    CAS  PubMed  Article  Google Scholar 

  14. Terris MK, McNeal JE, Stamey TA (1992) Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies. J Urol 148:829–832

    CAS  PubMed  Google Scholar 

  15. Damiano R, Di Lorenzo G, Cantiello F, De Sio M, Perdonà S, D’Armiento M, Autorino R (2007) Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis. Eur Urol 52:648–657. doi:10.1016/j.eururo.2007.06.016

    PubMed  Article  Google Scholar 

  16. Alsinnawi M, Loftus B, Flynn R, McDermott T, Grainger R, Thornhill JA (2012) The incidence and relevance of prostate cancer in radical cystoprostatectomy specimens. Int Urol Nephrol 44:1705–1710. doi:10.1007/s11255-012-0224-y

    CAS  PubMed  Article  Google Scholar 

  17. Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA, Shappell SB (2004) Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 171:646–651. doi:10.1097/01.ju.0000107380.40481.bc

    PubMed  Article  Google Scholar 

  18. Gakis G, Schilling D, Bedke J, Sievert KD, Stenzl A (2010) Incidental prostate cancer at radical cystoprostatectomy: implications for apex-sparing surgery. BJU Int 105:468–471. doi:10.1111/j.1464-410X.2009.08739.x

    PubMed  Article  Google Scholar 

  19. Davila HH, Weber T, Burday D, Thurman S, Carrion R, Salup R, Lockhart JL (2007) Total or partial prostate sparing cystectomy for invasive bladder cancer: long-term implications on erectile function. BJU Int 100:1026–1029. doi:10.1111/j.1464-410X.2007.07169.x

    PubMed  Google Scholar 

  20. Ruffion A, Manel A, Massoud W et al (2005) Preservation of prostate during radical cystectomy: evaluation of prevalence of prostate cancer associated with bladder cancer. Urology 65:703–707. doi:10.1016/j.urology.2004.10.076

    CAS  PubMed  Article  Google Scholar 

  21. Muto G, Bardari F, D’Urso L, Giona C (2004) Seminal sparing cystectomy and ileocapsuloplasty: long-term followup results. J Urol 172:76–80. doi:10.1097/01.ju.0000132130.64727.b6

    CAS  PubMed  Article  Google Scholar 

  22. Colombo R, Bertini R, Salonia A et al (2004) Overall clinical outcomes after nerve and seminal sparing radical cystectomy for the treatment of organ confined bladder cancer. J Urol 171:1819–1822. doi:10.1097/01.ju.0000123781.49896.fe

    PubMed  Article  Google Scholar 

  23. Pepe P, Aragona F (2010) Incidence of insignificant prostate cancer using free/total PSA: results of a case-finding protocol on 14,453 patients. Prost Cancer Prost Dis 13:316–319. doi:10.1038/pcan.2010.29

    CAS  Article  Google Scholar 

  24. Schröder FH, Hugosson J, Roobol MJ et al (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360:1320–1328. doi:10.1056/NEJMoa0810084

    PubMed  Article  Google Scholar 

  25. Bul M, Zhu X, Valdagni R et al (2013) Active surveillance for low-risk prostate cancer worldwide: the PRIAS study. Eur Urol 63:597–603. doi:10.1016/j.eururo.2012.11.005

    PubMed  Article  Google Scholar 

  26. Wolters T, Montironi R, Mazzucchelli R et al (2012) Comparison of incidentally detected prostate cancer with screen-detected prostate cancer treated by prostatectomy. Prostate 72:108–115. doi:10.1002/pros.21415

    PubMed  Article  Google Scholar 

Download references

Conflict of interest

All the authors declare to have not any conflict of interest.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Filippo Fraggetta.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Pepe, P., Fraggetta, F., Galia, A. et al. Preoperative findings, pathological stage PSA recurrence in men with prostate cancer incidentally detected at radical cystectomy: our experience in 242 cases. Int Urol Nephrol 46, 1325–1328 (2014). https://doi.org/10.1007/s11255-014-0647-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-014-0647-8

Keywords

  • Prostate cancer
  • Radical cystectomy
  • Incidental prostate cancer
  • Insignificant prostate cancer